The Global Kashmir
No Result
View All Result
  • Home
  • News
    • Kashmir
    • Jammu
  • National
  • World
  • Business
  • Editorial
  • Health
  • Opinion
  • Sports
  • Tech
  • E-Paper
en English
ar Arabiczh-CN Chinese (Simplified)en Englishru Russianes Spanishur Urdu
No Result
View All Result
  • Home
  • News
    • Kashmir
    • Jammu
  • National
  • World
  • Business
  • Editorial
  • Health
  • Opinion
  • Sports
  • Tech
  • E-Paper
No Result
View All Result
The Global Kashmir
No Result
View All Result

Common diabetes drug price slashed in India due to generic versions

News Desk by News Desk
March 14, 2025
Reading Time: 2 mins read
0
69
VIEWS
Share on Facebook

New Delhi : The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic versions in the market.

READ ALSO

Covid Cases: Health Ministry Asks States To Ensure Availability Of Oxygen, Isolation Beds, Ventilators

40% of adults with chronic pain could have anxiety, depression: Study

DAK Urges Public to Adopt Safe Heating Practices to Prevent Tragedies During Winters

Developed by German pharma giant Boehringer Ingelheim (BI) empagliflozin, it is sold under the name Jardiance. It is an oral medication that helps control blood sugar in patients with type 2 diabetes.

The drug which costs around Rs 60 per tablet, will now be sold for Rs 5.5 per tablet. It comes as drugmakers Mankind, Alkem, Glenmark launched generic versions of empagliflozin.

In a statement, Mankind Pharma said that its Empagliflozin will now be sold at Rs 5.49 per tablet for the 10 mg variant and Rs 9.90 per tablet for the 25 mg variant.

“We are ensuring that cost is no longer a barrier to access,” said Rajeev Juneja, Vice Chairman and Managing Director, Mankind Pharma.

Alkem has launched the drug under the brand name Empanorm at nearly 80 per cent less than the cost of innovator products.

“With a patient-centric approach, Alkem has introduced anti-counterfeit security band on the pack of Empanorm, as well as comprehensive patient education information, including basic details on diabetes management in Hindi and English with infographics, and QR codes that provide prescribing information and additional patient education information on diabetes, heart failure, and chronic kidney disease in 11 languages,” Alkem said in a statement.

ADVERTISEMENT

Mumbai-based Glenmark Pharmaceuticals has also introduced a generic drug of Empagliflozin under the brand name Glempa (Empagliflozin 10/25 mg), along with its fixed-dose combinations Glempa-L (Empagliflozin 10/25 mg + Linagliptin 5 mg) and Glempa-M (Empagliflozin 12.5 mg + Metformin 500/1000 mg).

“The launch of Glempa range reinforces this commitment by providing a comprehensive and affordable solution that empowers healthcare professionals and patients to manage type 2 diabetes with established cardiovascular disease more effectively,” said Alok Malik, President and Head of India Formulations Business, Glenmark Pharmaceuticals.

India is known as the diabetes capital of the world with over 10 crore people diagnosed with the lifestyle disease, as per the Indian Council of Medical Research–India Diabetes (ICMR INDIAB) study in 2023.

Lowering the cost of anti-diabetes medicines may be a crucial step in tackling the disease burden. — (IANS)

ShareTweetSendSharePinShare
ADVERTISEMENT
Previous Post

District task force rescued nine homeless street children in Jammu

Next Post

J&K Waqf Board chief Darakhshan Andrabi supports ban on separatist outfits

RelatedPosts

First Case Of Vocal Cord Paralysis Following Covid Infection In Teenager Reported In New Study

Covid Cases: Health Ministry Asks States To Ensure Availability Of Oxygen, Isolation Beds, Ventilators

June 5, 2025
40% of adults with chronic pain could have anxiety, depression: Study

40% of adults with chronic pain could have anxiety, depression: Study

March 11, 2025
Doctors Association Kashmir Appeals for Emergency Transport Services for Healthcare Employees Amid Heavy Snowfall

DAK Urges Public to Adopt Safe Heating Practices to Prevent Tragedies During Winters

January 6, 2025

Heart attacks, heart failure incidences rise in winter: General Physician Dr. Tarun Sahni

GMC Srinagar issues advisory regarding heart attacks in cold weather

Over 5,200 cancer patients registered at SKIMS this year; 50,000 since 2014

Switching off from work can be difficult but taking proper break is good for your health

New study links paracetamol to side effects in digestive tract, heart, kidneys among older adults

Study estimates over 62m tuberculosis cases, 8m related deaths in India during 2021-2040

Next Post
Eid Prayers Likely To Be Offered At Eidgah Srinagar: Darakhshan Andrabi

J&K Waqf Board chief Darakhshan Andrabi supports ban on separatist outfits

Srinagar Police’s Lok Darbar Witnesses Overwhelming Public Participation in Nowhatta, Srinagar

Srinagar Police’s Lok Darbar Witnesses Overwhelming Public Participation in Nowhatta, Srinagar

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

Company Info

Address: F11 silk factory road Tulsibagh, Srinagar
Phone : 9797970347.
Email : globalkashmir786@gmail.com
Owner, printer, publisher Editor : Suhail Yousuf Shah
Legal advisor : Advocate Umar Mushtaq
Printed at : LUBAAB PUBLICATIONS LAWAYPORA SRINAGAR
Published from : Green house Soitang, Srinagar, Kashmir.
RNI No : JKENG/2011/38364
Office No's :
Postal Regd No : JKNP 160 / SKGPO 2012 - 2014

About

The Global Kashmir was founded in Srinagar, with a vision to promote positive news from the Kashmir valley and across the globe. Covering first hand, all categories of news from different corners of Jammu and Kashmir as well as relevant national and international news stories. Global Kashmir is dedicated to providing unbiased stories that are yet to be told...

News By Topic

Company Info

  • Contact Us
  • About

© 2022 - Global Kashmir

No Result
View All Result
  • Home
  • News
    • Kashmir
    • Jammu
  • National
  • World
  • Business
  • Editorial
  • Health
  • Opinion
  • Sports
  • Tech
  • E-Paper

© 2022 - Global Kashmir